Apimeds Pharmaceuticals US, Inc
APUSEarnings History
| Report Date | EPS Actual | EPS Est. | Revenue Actual | Revenue Est. |
|---|---|---|---|---|
| Aug 14, 2026 | $-11.77 | — | — | — |
| May 26, 2026 | $-22.60 | — | — | — |
| Nov 12, 2025 | $-0.14 | — | — | — |
| Aug 19, 2025 | $-0.26 | — | — | — |
| May 19, 2025 | $-0.35 | — | — | — |
News
AUSTIN, Texas, Nov. 03, 2026 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest CryptoCurrencyWire Audio Production as part of its sustained effort to provide specialized content distribution via widespread syndication channels. CryptoCurrencyWire's latest audio production features Dr. Vin Menon, CEO of MindWave Innovations Inc. (NYSE American: APUS), a …
Trading opens Wednesday, Oct. 14, 2026, at 6 a.m. ET on Pionex, a global cryptocurrency exchange known for its built-in automated trading bots Trading opens Wednesday, Oct. 14, 2026, at 6 a.m. ET on Pionex, a global cryptocurrency exchange known for its built-in automated trading bots
MATAWAN, N. J. , Oct. 09, 2026 (GLOBE NEWSWIRE) -- via IBN - MindWave Innovations Inc. USA ("MindWave"), a wholly owned subsidiary of Apimeds Pharmaceuticals US, Inc.
MATAWAN, N.J., Sept. 29, 2026 (GLOBE NEWSWIRE) -- MindWave Innovations Inc. ("MindWave"), a wholly owned subsidiary of Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS), has signed a 12-month software development and technology services agreement with New York-based Flash Sports & Media Holdings, Inc. (FLZH) to build and operate FlashChain, a blockchain for tracking digital broadcasting rights, video assets and match ticket inventory.
Apimeds Pharmaceuticals US Inc. (NYSE:APUS) shares are surging Thursday morning after its wholly owned subsidiary, MindWave Innovations Inc., announced a 12-month technology services agreement with Singapore-based AQUAE Holdings Pte. Ltd. to build and operate AQUAEChain.
MindWave will supply and operate the technology, while AQUAE leads the ALCI Credits methodology, brand and market development MindWave will supply and operate the technology, while AQUAE leads the ALCI Credits methodology, brand and market development
AUSTIN, Texas, Sept. 18, 2026 (GLOBE NEWSWIRE) -- via IBN – Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) has engaged IBN, a multifaceted financial news and publishing company serving private and public entities, to assist with its corporate communications strategy.